Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal

por Koska, Valeria, Förster, Moritz, Brouzou, Katja, Arat, Ercan, Albrecht, Philipp, Aktas, Orhan, Küry, Patrick, Meuth, Sven G., Kremer, David
Publicado 2021

Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue

por Koska, Valeria, Förster, Moritz, Brouzou, Katja, Hatami, Maryam, Arat, Ercan, Aytulun, Ahmet, Albrecht, Philipp, Aktas, Orhan, Küry, Patrick, Meuth, Sven G., Kremer, David
Publicado 2021

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

por Nelke, Christopher, Stascheit, Frauke, Eckert, Carmen, Pawlitzki, Marc, Schroeter, Christina B., Huntemann, Niklas, Mergenthaler, Philipp, Arat, Ercan, Öztürk, Menekse, Foell, Dirk, Schreiber, Stefanie, Vielhaber, Stefan, Gassa, Asmae, Stetefeld, Henning, Schroeter, Michael, Berger, Benjamin, Totzeck, Andreas, Hagenacker, Tim, Meuth, Sven G., Meisel, Andreas, Wiendl, Heinz, Ruck, Tobias
Publicado 2022

Eculizumab versus rituximab in generalised myasthenia gravis

por Nelke, Christopher, Schroeter, Christina B, Stascheit, Frauke, Pawlitzki, Marc, Regner-Nelke, Liesa, Huntemann, Niklas, Arat, Ercan, Öztürk, Menekse, Melzer, Nico, Mergenthaler, Philipp, Gassa, Asmae, Stetefeld, Henning, Schroeter, Michael, Berger, Benjamin, Totzeck, Andreas, Hagenacker, Tim, Schreiber, Stefanie, Vielhaber, Stefan, Hartung, Hans-Peter, Meisel, Andreas, Wiendl, Heinz, Meuth, Sven G, Ruck, Tobias
Publicado 2022